Dr. Jensen-Akula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6143 Ocean View Dr
Oakland, CA 94618Phone+1 510-821-0199Fax+1 510-547-8865- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1973 - 1976- University of California San Francisco School of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1975 - 2025
MD State Medical License 1978 - 1980- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 11 citationsNephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.Kenneth C. Micetich, Michael Jensen-Akula, Jean Claude Mandard, Richard I. Fisher> ;The American Journal of Medicine. 1981 Dec 1
- Selected anticancer drugs in Phase I trials in the United States (1979--1980).Muggia, F. M., Penta, J. S., Catane, R., Jensen-Akula, M. S., Charles, L. M.> ;Recent Results Cancer Res. 1981
- Phase II trials: use of a clinical tumor panel and overview of current resources and studies.Muggia, F. M., Rozencweig, M., Chiuten, D. F., Jensen-Akula, M. S., Charles, L. M., Kubota, T. T., Bono, V. H.> ;Cancer Treat Rep. 1980 Jan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
